Thermo Fisher Scientific (TMO) Shares Outstanding (Diluted Average) (2009 - 2026)

Thermo Fisher Scientific has disclosed Shares Outstanding (Diluted Average) across 15 years of filings, most recently posting $373.0 million for Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) fell 1.58% year-over-year to $373.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $373.0 million (down 1.58% YoY) and the FY2025 annual result came in at $378.0 million, down 1.31% from the prior year.
• Shares Outstanding (Diluted Average) fell to $373.0 million in Q1 2026, from $378.0 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $395.0 million in Q2 2022 and troughed at $373.0 million in Q1 2026.
• A 5-year average of $385.3 million and a median of $384.0 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) dropped 0.5% — and 2023, when it declined 1.77%.
• Tracing TMO's Shares Outstanding (Diluted Average) over 5 years: stood at $394.0 million in 2022, then decreased by 1.52% to $388.0 million in 2023, then retreated by 1.29% to $383.0 million in 2024, then retreated by 1.31% to $378.0 million in 2025, then declined by 1.32% to $373.0 million in 2026.
• Business Quant data shows TMO's Shares Outstanding (Diluted Average) at $373.0 million in Q1 2026, $378.0 million in Q4 2025, and $378.0 million in Q3 2025.